MARKET

CAI

CAI

Caris Life Sciences, Inc.
NASDAQ
25.57
+0.34
+1.35%
Pre Market: 25.57 0 0.00% 04:01 11/10 EST
OPEN
25.29
PREV CLOSE
25.23
HIGH
26.02
LOW
24.60
VOLUME
8
TURNOVER
--
52 WEEK HIGH
36.50
52 WEEK LOW
14.19
MARKET CAP
7.33B
P/E (TTM)
75.94
1D
5D
1M
3M
1Y
5Y
1D
BTSG vs. CAI: Which Stock Should Value Investors Buy Now?
NASDAQ · 19h ago
Weekly Report: what happened at CAI last week (1102-1106)?
Weekly Report · 1d ago
Caris Life Sciences Is Maintained at Buy by Citigroup
Dow Jones · 3d ago
Caris Life Sciences Price Target Raised to $36.00/Share From $28.00 by Citigroup
Dow Jones · 3d ago
Citigroup Maintains Buy on Caris Life Sciences, Raises Price Target to $36
Benzinga · 3d ago
Analysts Offer Insights on NA Companies: Canadian National Railway (CNI), Caris Life Sciences, Inc. (CAI) and Figma, Inc. Class A (FIG)
TipRanks · 3d ago
Caris Life Sciences price target raised to $36 from $28 at Citi
TipRanks · 3d ago
Analysts Conflicted on These NA Names: Lyntris Inc (LYNX), Ardent Health Partners, Inc. (ARDT) and Caris Life Sciences, Inc. (CAI)
TipRanks · 4d ago
More
About CAI
Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.

Webull offers Caris Life Sciences, Inc. stock information, including NASDAQ: CAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CAI stock methods without spending real money on the virtual paper trading platform.